The Polycomb group protein EZH2 directly controls DNA methylation
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The establishment and maintenance of epigenetic gene silencing is fundamental to cell determination and function. The essential epigenetic systems involved in heritable repression of gene activity are the Polycomb group (PcG) proteins and the DNA methylation systems. Here we show that the corresponding silencing pathways are mechanistically linked. We find that the PcG protein EZH2 (Enhancer of Zeste homolog 2) interacts-within the context of the Polycomb repressive complexes 2 and 3 (PRC2/3)-with DNA methyltransferases (DNMTs) and associates with DNMT activity in vivo. Chromatin immunoprecipitations indicate that binding of DNMTs to several EZH2-repressed genes depends on the presence of EZH2. Furthermore, we show by bisulphite genomic sequencing that EZH2 is required for DNA methylation of EZH2-target promoters. Our results suggest that EZH2 serves as a recruitment platform for DNA methyltransferases, thus highlighting a previously unrecognized direct connection between two key epigenetic repression systems.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Neither did Dnmt3a, another chromatin modifying enzyme that is a PRC2 component and is frequently genetically inactivated in myeloid neoplasms (Fig. 5) (31”
From Runx1 regulation of Pu.1 corepressor/coactivator exchange identifies specific molecular targets for leukemia differentiation therapy (2014) · cites this paper as [32]
Citations
Cites
DNA methylation patterns and epigenetic memory
Bird, A. (2002) · Genes & Development · doi:10.1101/gad.947102 · Cited by 7,124
Jaenisch, R., & Bird, A. (2003) · Nature Genetics · doi:10.1038/ng1089 · Cited by 6,325
Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing
Cao, R., Wang, L., Wang, H., Xia, L., Erdjument-Bromage, H., Tempst, P., Jones, R. S., & Zhang, Y. (2002) · Science · doi:10.1126/science.1076997 · Cited by 3,775
Epigenetics in human disease and prospects for epigenetic therapy
Egger, G., Liang, G., Aparicio, A., & Jones, P. A. (2004) · Nature · doi:10.1038/nature02625 · Cited by 3,232
Kuzmichev, A., Nishioka, K., Erdjument-Bromage, H., Tempst, P., & Reinberg, D. (2002) · Genes & Development · doi:10.1101/gad.1035902 · Cited by 1,596
Histone Methyltransferase Activity of a Drosophila Polycomb Group Repressor Complex
Müller, J., Hart, C. M., Francis, N. J., Vargas, M. L., Sengupta, A., Wild, B., Miller, E. L., O'Connor, M. B., Kingston, R. E., & Simon, J. A. (2002) · Cell · doi:10.1016/s0092-8674(02)00976-5 · Cited by 1,562
Czermin, B., Melfi, R., McCabe, D., Seitz, V., Imhof, A., & Pirrotta, V. (2002) · Cell · doi:10.1016/s0092-8674(02)00975-3 · Cited by 1,533
Control of CpNpG DNA methylation by the KRYPTONITE histone H3 methyltransferase
Jackson, J. P., Lindroth, A. M., Cao, X., & Jacobsen, S. E. (2002) · Nature · doi:10.1038/nature731 · Cited by 1,251
Lehnertz, B., Ueda, Y., Derijck, A. A. H. A., Braunschweig, U., Perez-Burgos, L., Kubicek, S., Chen, T., Li, E., Jenuwein, T., & Peters, A. H. F. M. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00432-9 · Cited by 1,245
Role of Histone H3 Lysine 27 Methylation in X Inactivation
Plath, K., Fang, J., Mlynarczyk-Evans, S. K., Cao, R., Worringer, K. A., Wang, H., de la Cruz, C. C., Otte, A. P., Panning, B., & Zhang, Y. (2003) · Science · doi:10.1126/science.1084274 · Cited by 1,195
Cited by
Items 201–300 of 1,004
Regulation of Muscle Stem Cell Functions: A Focus on the p38 MAPK Signaling Pathway
Segalés, J., Perdiguero, E., & Muñoz-Cánoves, P. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2016.00091 · Cited by 206
“…Pax7 ablation leads to the loss of adult satellite cells, which results in impaired muscle regeneration after injury confirming that Pax7+ satellite cells are sufficient and required for adult muscle repair (Lepper et al., 2011; Sambasivan et al., 2011; von Maltzahn et al., 2013; Brack, 2014).”
BackgroundConcise Review: Roles of Polycomb Group Proteins in Development and Disease: A Stem Cell Perspective
Rajasekhar, V. K., & Begemann, M. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0608 · Cited by 205
Targeting DNA Methylation and EZH2 Activity to Overcome Melanoma Resistance to Immunotherapy
Emran, A. A., Chatterjee, A., Rodger, E. J., Tiffen, J. C., Gallagher, S. J., Eccles, M. R., & Hersey, P. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.02.004 · Cited by 205
Maternal Obesity, Inflammation, and Fetal Skeletal Muscle Development1
Du, M., Yan, X., Tong, J. F., Zhao, J., & Zhu, M. J. (2010) · Biology of Reproduction · doi:10.1095/biolreprod.109.077099 · Cited by 204
Genomic regulatory blocks underlie extensive microsynteny conservation in insects
Engström, P. G., Ho Sui, S. J., Drivenes, Ø., Becker, T. S., & Lenhard, B. (2007) · Genome Research · doi:10.1101/gr.6669607 · Cited by 204
Luo, J., Wang, K., Yeh, S., Sun, Y., Liang, L., Xiao, Y., Xu, W., Niu, Y., Cheng, L., Maity, S. N., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09784-9 · Cited by 204
Coordinated Regulation of Polycomb Group Complexes through microRNAs in Cancer
Cao, Q., Mani, R.-S., Ateeq, B., Dhanasekaran, S. M., Asangani, I. A., Prensner, J. R., Kim, J. H., Brenner, J. C., Jing, X., Cao, X., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.06.016 · Cited by 204
Allosteric control of mammalian DNA methyltransferases – a new regulatory paradigm
Jeltsch, A., & Jurkowska, R. Z. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw723 · Cited by 203
Cross-talk between Site-specific Transcription Factors and DNA Methylation States
Blattler, A., & Farnham, P. J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.r113.512517 · Cited by 203
Willemsen, M. H., Vallès, A., Kirkels, L. A. M. H., Mastebroek, M., Olde Loohuis, N., Kos, A., Wissink-Lindhout, W. M., de Brouwer, A. P. M., Nillesen, W. M., Pfundt, R., et al. (2011) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2011-100294 · Cited by 202
Epigenetic regulation of the INK4b-ARF-INK4a locus: In sickness and in health
Popov, N., & Gil, J. (2010) · Epigenetics · doi:10.4161/epi.5.8.12996 · Cited by 202
How to stomach an epigenetic insult: the gastric cancer epigenome
Padmanabhan, N., Ushijima, T., & Tan, P. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.53 · Cited by 202
Stefanska, B., Karlic, H., Varga, F., Fabianowska‐Majewska, K., & Haslberger, A. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02002.x · Cited by 200
Chromatin structure and epigenetics
Quina, A. S., Buschbeck, M., & Di Croce, L. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.06.016 · Cited by 200
Epigenetic alterations involved in cancer stem cell reprogramming
Muñoz, P., Iliou, M. S., & Esteller, M. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.10.006 · Cited by 200
Self-citationColorectal Cancer Epigenetics: Complex Simplicity
van Engeland, M., Derks, S., Smits, K. M., Meijer, G. A., & Herman, J. G. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.2319 · Cited by 199
Epigenetic mechanisms linking early nutrition to long term health
Lillycrop, K. A., & Burdge, G. C. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2012.03.009 · Cited by 197
Promoter targeted small RNAs induce long-term transcriptional gene silencing in human cells
Hawkins, P. G., Santoso, S., Adams, C., Anest, V., & Morris, K. V. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp127 · Cited by 197
“Recent work indicates that this putative TSC may contain DNMT3a (10), Ago-1 (2,9), HDAC-1 (14) and histone methyltransferases such as enhancer of zeste homolog 2 (Ezh2) and/or G9a (4, 15 ).”
BackgroundEndocrine-disrupting Chemicals: Review of Toxicological Mechanisms Using Molecular Pathway Analysis
Yang, O., Kim, H. L., Weon, J.-I., & Seo, Y. R. (2015) · Journal of Cancer Prevention · doi:10.15430/jcp.2015.20.1.12 · Cited by 196
The control of histone lysine methylation in epigenetic regulation
Völkel, P., & Angrand, P.-O. (2007) · Biochimie · doi:10.1016/j.biochi.2006.07.009 · Cited by 195
Methylation-based classification of benign and malignant peripheral nerve sheath tumors
Röhrich, M., Koelsche, C., Schrimpf, D., Capper, D., Sahm, F., Kratz, A., Reuss, J., Hovestadt, V., Jones, D. T. W., Bewerunge-Hudler, M., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1540-6 · Cited by 194
Breast Cancer Epigenetics: From DNA Methylation to microRNAs
Veeck, J., & Esteller, M. (2010) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-010-9165-1 · Cited by 193
Self-citationOugolkov, A. V., Bilim, V. N., & Billadeau, D. D. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1013 · Cited by 193
Enhancer of Zeste Homologue 2 (EZH2) Down-regulates RUNX3 by Increasing Histone H3 Methylation
Fujii, S., Ito, K., Ito, Y., & Ochiai, A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800224200 · Cited by 193
Selective Anchoring of DNA Methyltransferases 3A and 3B to Nucleosomes Containing Methylated DNA
Jeong, S., Liang, G., Sharma, S., Lin, J. C., Choi, S. H., Han, H., Yoo, C. B., Egger, G., Yang, A. S., & Jones, P. A. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00484-09 · Cited by 192
A DNA methylation‐based definition of biologically distinct breast cancer subtypes
Stefansson, O. A., Moran, S., Gomez, A., Sayols, S., Arribas-Jorba, C., Sandoval, J., Hilmarsdottir, H., Olafsdottir, E., Tryggvadottir, L., Jonasson, J. G., et al. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2014.10.012 · Cited by 192
Self-citationDNA Methylation Dictates Histone H3K4 Methylation
Okitsu, C. Y., & Hsieh, C.-L. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02291-06 · Cited by 157
Li, X., Zhang, Q., Ding, Y., Liu, Y., Zhao, D., Zhao, K., Shen, Q., Liu, X., Zhu, X., Li, N., et al. (2016) · Nature Immunology · doi:10.1038/ni.3464 · Cited by 190
Epigenetics of haematopoietic cell development
Cedar, H., & Bergman, Y. (2011) · Nature Reviews Immunology · doi:10.1038/nri2991 · Cited by 189
Neri, F., Krepelova, A., Incarnato, D., Maldotti, M., Parlato, C., Galvagni, F., Matarese, F., Stunnenberg, H. G., & Oliviero, S. (2013) · Cell · doi:10.1016/j.cell.2013.08.056 · Cited by 186
Ning, X., Shi, Z., Liu, X., Zhang, A., Han, L., Jiang, K., Kang, C., & Zhang, Q. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.01.005 · Cited by 185
Candidate silencer elements for the human and mouse genomes
Doni Jayavelu, N., Jajodia, A., Mishra, A., & Hawkins, R. D. (2020) · Nature Communications · doi:10.1038/s41467-020-14853-5 · Cited by 184
The roles of EZH2 in cancer and its inhibitors
Liu, Y., & Yang, Q. (2023) · Medical Oncology · doi:10.1007/s12032-023-02025-6 · Cited by 185
Epigenetics and its implications for ecotoxicology
Vandegehuchte, M. B., & Janssen, C. R. (2011) · Ecotoxicology · doi:10.1007/s10646-011-0634-0 · Cited by 183
DNA methylation dynamics in aging: how far are we from understanding the mechanisms?
Ciccarone, F., Tagliatesta, S., Caiafa, P., & Zampieri, M. (2018) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.12.002 · Cited by 183
STAT3 signaling drives EZH2 transcriptional activation and mediates poor prognosis in gastric cancer
Pan, Y.-M., Wang, C.-G., Zhu, M., Xing, R., Cui, J.-T., Li, W.-M., Yu, D.-D., Wang, S.-B., Zhu, W., Ye, Y.-J., et al. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0561-z · Cited by 183
Tissue-specific disallowance of housekeeping genes: The other face of cell differentiation
Thorrez, L., Laudadio, I., Van Deun, K., Quintens, R., Hendrickx, N., Granvik, M., Lemaire, K., Schraenen, A., Van Lommel, L., Lehnert, S., et al. (2011) · Genome Research · doi:10.1101/gr.109173.110 · Cited by 183
MYC—Master Regulator of the Cancer Epigenome and Transcriptome
Poole, C. J., & Van Riggelen, J. (2017) · Genes · doi:10.3390/genes8050142 · Cited by 183
Maintaining differentiated cellular identity
Holmberg, J., & Perlmann, T. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3209 · Cited by 185
DNA methylation and gene expression
Siegfried, Z., & Simon, I. (2010) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.64 · Cited by 181
EZH2 negatively regulates PD-L1 expression in hepatocellular carcinoma
Xiao, G., Jin, L.-L., Liu, C.-Q., Wang, Y.-C., Meng, Y.-M., Zhou, Z.-G., Chen, J., Yu, X.-J., Zhang, Y.-J., Xu, J., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0784-9 · Cited by 179
Modifications of RNA polymerase II are pivotal in regulating gene expression states
Brookes, E., & Pombo, A. (2009) · EMBO reports · doi:10.1038/embor.2009.221 · Cited by 152
Developmental Programming of Fetal Skeletal Muscle and Adipose Tissue Development
Yan, X., Zhu, M.-J., Dodson, M. V., & Du, M. (2013) · Journal of Genomics · doi:10.7150/jgen.3930 · Cited by 150
Prenatal stress and epigenetics
Cao-Lei, L., de Rooij, S. R., King, S., Matthews, S. G., Metz, G. A. S., Roseboom, T. J., & Szyf, M. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.05.016 · Cited by 178
EZH2 in normal and malignant hematopoiesis
Lund, K., Adams, P. D., & Copland, M. (2014) · Leukemia · doi:10.1038/leu.2013.288 · Cited by 178
Role of DNA methylation in miR-200c/141 cluster silencing in invasive breast cancer cells
Neves, R., Scheel, C., Weinhold, S., Honisch, E., Iwaniuk, K. M., Trompeter, H.-I., Niederacher, D., Wernet, P., Santourlidis, S., & Uhrberg, M. (2010) · BMC Research Notes · doi:10.1186/1756-0500-3-219 · Cited by 178
Bredfeldt, T. G., Greathouse, K. L., Safe, S. H., Hung, M.-C., Bedford, M. T., & Walker, C. L. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0438 · Cited by 178
Paschos, K., Smith, P., Anderton, E., Middeldorp, J. M., White, R. E., & Allday, M. J. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000492 · Cited by 177
Peng, Y., Zhao, J.-L., Peng, Z.-Y., Xu, W.-F., & Yu, G.-L. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2545-6 · Cited by 177
D’Alessio, A. C., & Szyf, M. (2006) · Biochemistry and Cell Biology · doi:10.1139/o06-090 · Cited by 138
DNA methylation of cancer genome
Cheung, H., Lee, T., Rennert, O. M., & Chan, W. (2009) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.20163 · Cited by 177
SMYD3 Promotes Cancer Invasion by Epigenetic Upregulation of the Metalloproteinase MMP-9
Cock-Rada, A. M., Medjkane, S., Janski, N., Yousfi, N., Perichon, M., Chaussepied, M., Chluba, J., Langsley, G., & Weitzman, J. B. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1052 · Cited by 174
Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma
Pogribny, I. P., & Rusyn, I. (2014) · Cancer Letters · doi:10.1016/j.canlet.2012.01.038 · Cited by 174
Ueno-Yokohata, H., Okita, H., Nakasato, K., Akimoto, S., Hata, J.-I., Koshinaga, T., Fukuzawa, M., & Kiyokawa, N. (2015) · Nature Genetics · doi:10.1038/ng.3338 · Cited by 174
Lodha, M., Marco, C. F., & Timmermans, M. C. P. (2013) · Genes & Development · doi:10.1101/gad.211425.112 · Cited by 173
“Digestion with McrBC, which cleaves methylated DNA, did not significantly reduce the levels of amplifiable DNA, whether from the promoter or gene body of BP and KNAT2 (Supplemental Fig.”
BackgroundInfluentialDNA methylation-based biomarkers in bladder cancer
Kandimalla, R., van Tilborg, A. A., & Zwarthoff, E. C. (2013) · Nature Reviews Urology · doi:10.1038/nrurol.2013.89 · Cited by 173
Boeva, V. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00024 · Cited by 174
Programming of gene expression by Polycomb group proteins
Köhler, C., & Villar, C. B. R. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.02.005 · Cited by 172
“EZH2 and DNA methyltransferases physically interact in mammaliancells, suggestingthat DNA methylation and PcGrepressionarecoordinatedtostabilizesilencingofPcG target genes [ 47 ].”
BackgroundEpigenetics and airways disease
Adcock, I. M., Ford, P., Ito, K., & Barnes, P. J. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-21 · Cited by 152
Shafei, A., Ramzy, M. M., Hegazy, A. I., Husseny, A. K., EL-hadary, U. G., Taha, M. M., & Mosa, A. A. (2018) · Gene · doi:10.1016/j.gene.2018.01.016 · Cited by 174
Epigenetic regulation of stem cell fate
Lunyak, V. V., & Rosenfeld, M. G. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn149 · Cited by 172
Shaver, S., Casas-Mollano, J. A., Cerny, R. L., & Cerutti, H. (2010) · Epigenetics · doi:10.4161/epi.5.4.11608 · Cited by 171
Dietary Manipulation of Histone Structure and Function
Delage, B., & Dashwood, R. H. (2008) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.28.061807.155354 · Cited by 155
HIV Latency: Should We Shock or Lock?
Darcis, G., Driessche, B. V., & Lint, C. M. V. (2017) · Trends in Immunology · doi:10.1016/j.it.2016.12.003 · Cited by 171
Niu, Z., Jin, R., Zhang, Y., & Li, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01200-x · Cited by 170
Ezh2-dCas9 and KRAB-dCas9 enable engineering of epigenetic memory in a context-dependent manner
O’Geen, H., Bates, S. L., Carter, S. S., Nisson, K. A., Halmai, J., Fink, K. D., Rhie, S. K., Farnham, P. J., & Segal, D. J. (2019) · Epigenetics & Chromatin · doi:10.1186/s13072-019-0275-8 · Cited by 169
Lu, L., Zhu, G., Zhang, C., Deng, Q., Katsaros, D., Mayne, S. T., Risch, H. A., Mu, L., Canuto, E. M., Gregori, G., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2314-z · Cited by 169
Interplay Between Different Epigenetic Modifications and Mechanisms
Murr, R. (2010) · Advances in genetics · doi:10.1016/b978-0-12-380866-0.60005-8 · Cited by 173
Glinsky, G. V. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.0266 · Cited by 169
Endocrine disrupting chemical Bisphenol A and its potential effects on female health
Kawa, I. A., masood, A., Fatima, Q., Mir, S. A., Jeelani, H., Manzoor, S., & Rashid, F. (2021) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2021.03.031 · Cited by 168
Lin, P.-C., Chiu, Y.-L., Banerjee, S., Park, K., Mosquera, J. M., Giannopoulou, E., Alves, P., Tewari, A. K., Gerstein, M. B., Beltran, H., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2968 · Cited by 168
MicroRNA in Glioblastoma: An Overview
Banelli, B., Forlani, A., Allemanni, G., Morabito, A., Pistillo, M. P., & Romani, M. (2017) · International Journal of Genomics · doi:10.1155/2017/7639084 · Cited by 168
Li, W., Zheng, J., Deng, J., You, Y., Wu, H., Li, N., Lu, J., & Zhou, Y. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.03.002 · Cited by 168
Cheng, D., Deng, J., Zhang, B., He, X., Meng, Z., Li, G., Ye, H., Zheng, S., Wei, L., Deng, X., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.08.055 · Cited by 167
BPA-Induced Deregulation Of Epigenetic Patterns: Effects On Female Zebrafish Reproduction
Santangeli, S., Maradonna, F., Gioacchini, G., Cobellis, G., Piccinetti, C. C., Valle, L. D., & Carnevali, O. (2016) · Scientific Reports · doi:10.1038/srep21982 · Cited by 167
Song, Y., Wu, F., & Wu, J. (2016) · Journal of Hematology & Oncology · doi:10.1186/s13045-016-0279-9 · Cited by 166
Taberlay, P. C., & Jones, P. A. (2011) · Epigenetics and Disease · doi:10.1007/978-3-7643-8989-5_1 · Cited by 165
Germline mutations in the oncogene EZH2 cause Weaver syndrome and increased human height
Tatton-Brown, K., The Childhood Overgrowth Collaboration, Hanks, S., Ruark, E., Zachariou, A., Duarte, S. D. V., Ramsay, E., Snape, K., Murray, A., Perdeaux, E. R., et al. (2011) · Oncotarget · doi:10.18632/oncotarget.385 · Cited by 165
DNA methylation‐mediated epigenetic control
Rottach, A., Leonhardt, H., & Spada, F. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22253 · Cited by 167
Mechanisms and Disease Associations of Haplotype-Dependent Allele-Specific DNA Methylation
Do, C., Lang, C. F., Lin, J. P., Darbary, H. K., Krupska, I., Gaba, A., Petukhova, L., Vonsattel, J., GALLAGHER, M. P., Goland, R., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.03.027 · Cited by 165
DNA Methylation Targeting: The DNMT/HMT Crosstalk Challenge
Castillo-Aguilera, O., Depreux, P., Halby, L., Arimondo, P., & Goossens, L. (2017) · Biomolecules · doi:10.3390/biom7010003 · Cited by 164
Yang, X., Karuturi, R. K. M., Sun, F., Aau, M., Yu, K., Shao, R., Miller, L. D., Tan, P. B. O., & Yu, Q. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005011 · Cited by 164
Kundaković, M., Chen, Y., Guidotti, A., & Grayson, D. R. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.051763 · Cited by 164
Bugide, S., Green, M. R., & Wajapeyee, N. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1802691115 · Cited by 155
Transcriptional and hormonal signaling control of Arabidopsis seed development
Sun, X., Shantharaj, D., Kang, X., & Ni, M. (2010) · Current Opinion in Plant Biology · doi:10.1016/j.pbi.2010.08.009 · Cited by 164
Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence
Katz, L. M., Hielscher, T., Liechty, B., Silverman, J., Zagzag, D., Sen, R., Wu, P., Golfinos, J. G., Reuss, D., Neidert, M. C., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1844-9 · Cited by 163
CpG island chromatin: A platform for gene regulation
Blackledge, N. P., & Klose, R. (2011) · Epigenetics · doi:10.4161/epi.6.2.13640 · Cited by 162
Zhang, Y., Rohde, C., Tierling, S., Jurkowski, T. P., Bock, C., Santacruz, D., Ragozin, S., Reinhardt, R., Groth, M., Walter, J., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000438 · Cited by 162
Methylation of homeobox genes is a frequent and early epigenetic event in breast cancer
Tommasi, S., Karm, D. L., Wu, X., Yen, Y., & Pfeifer, G. P. (2009) · Breast Cancer Research · doi:10.1186/bcr2233 · Cited by 162
Hellebrekers, D. M. E. I., Castermans, K., Viré, E., Dings, R. P. M., Hoebers, N. T. H., Mayo, K. H., oude Egbrink, M. G. A., Molema, G., Fuks, F., van Engeland, M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1609 · Cited by 150
Self-citationGlobal H3K27 trimethylation and EZH2 abundance in breast tumor subtypes
Holm, K., Grabau, D., Lövgren, K., Aradottir, S., Gruvberger-Saal, S., Howlin, J., Saal, L. H., Ethier, S. P., Bendahl, P.-O., Stål, O., et al. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.06.002 · Cited by 161
“Trimethylation of H3K27 is an epigenetic label mediating gene silencing and can function as a mark for de novo DNA methylation in cancer cells by recruitment of DNA methyltransferases (DNMTs) (Ohm et al., 2007; Schlesinger et al., 2007; Vire et al., 2006).”
BackgroundSkalska, L., White, R. E., Franz, M., Ruhmann, M., & Allday, M. J. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000951 · Cited by 136
EZH2, an epigenetic driver of prostate cancer
Yang, Y. A., & Yu, J. (2013) · Protein & Cell · doi:10.1007/s13238-013-2093-2 · Cited by 163
The Epigenetic Hallmarks of Cancer
Esteller, M., Dawson, M. A., Kadoch, C., Rassool, F. V., Jones, P. A., & Baylin, S. B. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0296 · Cited by 160
Self-citationEpigenome-based cancer risk prediction: rationale, opportunities and challenges
on behalf of the FORECEE (4C) Consortium, Widschwendter, M., Jones, A., Evans, I., Reisel, D., Dillner, J., Sundström, K., Steyerberg, E. W., Vergouwe, Y., Wegwarth, O., et al. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2018.30 · Cited by 160
Chang, Y., Sun, L., Kokura, K., Horton, J. R., Fukuda, M., Espejo, A., Izumi, V., Koomen, J. M., Bedford, M. T., Zhang, X., et al. (2011) · Nature Communications · doi:10.1038/ncomms1549 · Cited by 160
Genomic insights into cancer-associated aberrant CpG island hypermethylation
Sproul, D., & Meehan, R. R. (2013) · Briefings in Functional Genomics · doi:10.1093/bfgp/els063 · Cited by 162
CBX7 is a tumor suppressor in mice and humans
Forzati, F., Federico, A., Pallante, P., Abbate, A., Esposito, F., Malapelle, U., Sepe, R., Palma, G., Troncone, G., Scarfò, M., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58620 · Cited by 152
Epigenetics and MicroRNAs in Cancer
Ramassone, A., Pagotto, S., Veronese, A., & Visone, R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020459 · Cited by 162
Hu, S., Yu, L., Li, Z., Shen, Y., Wang, J., Cai, J., Xiao, L., & Wang, Z. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.8.12913 · Cited by 159
Metadata
- Authors
- Viré, E., Brenner, C., Deplus, R., Blanchon, L., Fraga, M., Didelot, C., Morey, L., Van Eynde, A., Bernard, D., Vanderwinden, J.-M., Bollen, M., Esteller, M., Di Croce, L., de Launoit, Y., & Fuks, F.
- Affiliations
- Université Libre de Bruxelles (BE)
- Spanish National Cancer Research Centre (ES)
- KU Leuven (BE)
- Corresponding author
- Fuks, François
- ORCID
- Venue
- Nature
- Published
- 2005-12-14
- Volume
- 439
- Issue
- 7078
- Pages
- 871-874
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2053421436
- Cited by
- 2,204
- References
- 27
- Citations by year
- 2026: 32 · 2025: 52 · 2024: 60 · 2023: 72 · 2022: 89 · 2021: 110 · 2020: 95 · 2019: 94 · 2018: 95 · 2017: 119 · 2016: 151 · 2015: 134 · 2014: 128 · 2013: 135 · 2012: 164
- FWCI
- 33.51
- Type
- journal article
- Language
- en
- Update notices
- erratum (2007-04-12)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Fédération Wallonie-Bruxelles
- Fondation pour la Recherche Médicale
- Ministerio de Economía y Competitividad
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Keywords
- EZH2, Polycomb group proteins, DNA methylation, DNA methyltransferases, polycomb repressive complex 2, epigenetic silencing, chromatin repression, promoter methylation, protein-protein interaction
- MeSH terms
- Enhancer of Zeste Homolog 2 Protein, DNA (Cytosine-5-)-Methyltransferases, DNA-Binding Proteins, HeLa Cells, Humans, Promoter Regions, Genetic, Protein Binding, Repressor Proteins, Substrate Specificity, Transcription Factors, CpG Islands, DNA Methylation, Gene Silencing, Epigenesis, Genetic, Chromatin Immunoprecipitation, Polycomb-Group Proteins, Polycomb Repressive Complex 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.